Cardiovascular COVID‑19 syndrome after‑effects
https://doi.org/10.24884/2072-6716-2022-23-1-19-26
Abstract
The most common manifestations of the post‑covid syndrome are cardiovascular disorders that occur both in practically healthy people and in patients who already suffered from cardiac pathology before COVID‑19. The aim of the study was to analyze the cardiovascular problems in patients after coronavirus infection. Materials and methods: 78 patients with laboratory confirmed coronavirus infection were examined, 12 weeks or more after the onset of the disease. The results of laboratory, instrumental research methods and functional tests were evaluated. Results. А wide range of cardiac disorders was registered in the group of patients who were practically healthy before coronavirus infection and in patients with arterial hypertension. Conclusion. Сontrol of hemodynamic parameters, ECG, ECHO‑KG are necessary for all patients with an initial lesion of the cardiovascular system, and for the majority of patients without comorbid pathology with cardiovascular risk factors and with manifestations of post‑covid syndrome. It will make it possible to develop algorithms for the treatment and rehabilitation of this category of patients.
About the Authors
A. S. Bagdasaryan
Kuban State Medical University
Russian Federation
Russian Federation
Arshak S. Bagdasaryan
Krasnodar
A. A. Sirunyants
Kuban State Medical University
Russian Federation
Russian Federation
Anna A. Sirunyants
Krasnodar
D. V. Pukhnyak
Kuban State Medical University
Russian Federation
Russian Federation
Dmitrii V. Pukhnyak
Krasnodar
Zh. A. Kamalyan
Kuban State Medical University
Russian Federation
Russian Federation
Zhanetta A. Kamalyan
Krasnodar
A. I. Remizova
Krasnodar Emergency Hospital
Russian Federation
Russian Federation
Anna I. Remizova
Krasnodar
N. A. Fedisheva
Krasnodar Emergency Hospital
Russian Federation
Russian Federation
Natalya A. Fedisheva
Krasnodar
References
1. Mandal S., Barnett J., Brill S. E. et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19 // Thorax. 2020.
2. NIHR Themed Review: Living with Covid-19. October 2020. Available at: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/ [Accessed April 08, 2021] https://doi.org/10.3310/themedreview_41169
3. Michelen M., Manoharan L., Elkheir N. et al. Characterising long-term COVID-19: a rapid living systematic review // medRxiv. 2020.
4. Logue J.K., Franko N. M., McCulloch D.J. et al. Sequelae in adults at 6 months after COVID-19 infection // JAMA Network Open. 2021. No. 4. e210830.
5. Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19 // JAMA. 2020. Vol. 324, No. 6. Р. 603–605.
6. Huang C., Huang L., Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // Lancet. 2021. Vol. 397. Р. 220–232.
7. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. (Electronic resourсe). https://www.nice.org.uk/guidance/ng188 (access date: 10.08.2021).
8. Fauci Introduces New Acronym for Long COVID at White House Briefing. Medscape (Electronic resourсe.) https://www.medscape.com/viewarticle/946419 (access date: 10.08.2021).
9. Venkatesan P. NICE guideline on long COVID // Lancet Respir. Med. 2021. Vol. 9, No. 2. Р. 129. PMID: 33453162. https://doi.org/10.1016/S2213–2600(21)00031-X.
10. Mendelson M., Nel J., Blumberg L., Madhi S. A., Dryden M., Stevens W. et al. Long-COVID: An evolving problem with an extensive impact // S. Afr. Med. J. 2020. Vol. 111, No. 1. Р. 10–12. PMID: 33403997 https://doi.org/10.7196/ SAMJ.2020.v111i11.15433.
11. Garg P., Arora U., Kumar A., Wig N. The “post-COVID” syndrome: how deep is the damage? // J. Med. Virol. 2021. Vol. 93, No. 2. Р. 673–674. PMID: 32852801. https://doi.org/10.1002/jmv.26465.
12. Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens J. S. et al. Post-acute COVID-19 syndrome // Nat. Med. 2021. Mar 22. PMID: 33753937. https://doi.org/10.1038/s41591.021.01283-z Online ahead of print.
13. Olshansky B., Cannom D., Fedorowski A. et al. Postural orthostatic tachycardia syndrome (POTS): a critical assessment // Prog. Cardiovasc. Dis. 2020. Vol. 63. Р. 263–270.
14. Shaw B.H., Stiles L. E., Bourne K. et al. The face of postural tachycardia syndrome — insights from a largecross-sectional online community-based survey // J. Intern. Med. 2019. Vol. 286, No. 4. Р. 438–448.
15. Dani M., Dirksen A., Taraborrelli P. et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies // Clin. Med. (Lond.). 2021. Vol. 21, No. 1. Р. e63-e67.
16. Goldstein D. S. The possible association between COVID-19 and postural tachycardia syndrome // Heart Rhythm. 2020. Vol. 18, No. 4. Р. 508–509.
17. Romero-Sánchez C.M., Díaz-Maroto I., Fernández-Díaz E. et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry // Neurology. 2020. Vol. 95, No. 8. Р. e1060–1070.
18. Ivannikov A. A., Esaulenko A. N., Vasilchenko M. K., Alidzhanova H. G., Petrikov S. S. COVID-19 and the cardiovascular system. Part II. Postcovid syndrome. Zhurnal im. N. V. Sklifosovsky “Emergency medical care”, 2021, Vol. 10, No. 2, рр. 248–258 [In Russ.]).
Review
For citations:
Bagdasaryan A.S., Sirunyants A.A., Pukhnyak D.V., Kamalyan Zh.A., Remizova A.I., Fedisheva N.A. Cardiovascular COVID‑19 syndrome after‑effects. EMERGENCY MEDICAL CARE. 2022;23(1):19-26. (In Russ.) https://doi.org/10.24884/2072-6716-2022-23-1-19-26
Views:
967
Email this article 